Administering Intravenous Alteplase (Tissue Plasminogen Activator [tPA])
ثبت نشده
چکیده
Step 1: Eligibility-The eligibility criteria for patients with acute ischemic stroke within 3 hours of symptom onset include: • An adult (> 18 years of age) • Exclusion of intrancranial hemorrhage by an imaging technique sensitive for the presence of hemorrhage • Arrives at the emergency department in time to be treated within 3 hours of symptom onset • The recommended dose of IV tPA is 0.9 mg/kg (not to exceed 90 mg total dose) infused over 60 minutes with 10% of the total dose administered as an initial bolus over 1 minute • The goal for treatment of IV tPA is to give bolus and initiate infusion to eligible patient in less than 60 minutes of patient arrival • See attached information regarding close observation and frequent monitoring of patients for neurologic changes, any signs/symptoms of intracranial hemorrhage, and any signs of adverse drug reactions are important during patient recovery.
منابع مشابه
Medicolegal Considerations with Intravenous Tissue Plasminogen Activator in Stroke: A Systematic Review
Background. Intravenous tPA (tissue plasminogen activator) therapy remains underutilized in patients with Acute Ischemic Stroke (AIS). Anecdotal data indicates that physicians are increasingly liable for administering and for failure to administer tPA. Methods. An extensive search of Medline, Embase, Westlaw, LexisNexis Legal, and Google Scholar databases was performed. Case studies that involv...
متن کاملMedico-Legal Aspects of Using Tissue Plasminogen Activator in Acute Ischemic Stroke
OPINION STATEMENT Intravenous alteplase or tissue plasminogen activator (tPA) has been the standard of care with proven efficacy for acute ischemic stroke for over a decade. Despite this, only a small fraction of potentially eligible stroke patients receive this medication. There seems to be a fear among practitioners of legal repercussions as a result of an increased risk of intracerebral hemo...
متن کاملVampire bat salivary plasminogen activator (desmoteplase) inhibits tissue-type plasminogen activator-induced potentiation of excitotoxic injury.
BACKGROUND AND PURPOSE In contrast to tissue-type plasminogen activator (tPA), vampire bat (Desmodus rotundus) salivary plasminogen activator (desmoteplase [DSPA]) does not promote excitotoxic injury when injected directly into the brain. We have compared the excitotoxic effects of intravenously delivered tPA and DSPA and determined whether DSPA can antagonize the neurotoxic and calcium enhanci...
متن کاملFurther randomized controlled trials of tissue plasminogen activator within 3 hours are required.
Why Are Stroke Physicians Uncertain of the Benefits of Early tPA? An independent national survey1 of 1716 stroke physicians in the United Kingdom reported that 74% were uncertain of the benefits of thrombolytic therapies. A recent United States survey2 reported that less than half of the responding neurologists had administered tPA and only 30% believed the efficacy of intravenous tPA was “very...
متن کاملIntravenous recombinant tissue plasminogen activator in a pregnant woman with cardioembolic stroke.
BACKGROUND AND PURPOSE Historically, the use of tissue plasminogen activator (tPA) thrombolysis in pregnancy has been regarded as relatively contraindicated. Underlying this stance has been the concern over the risk of bleeding complications in both mother and child. SUMMARY OF CASE We report the successful use of intravenous recombinant tPA (rtPA) thrombolysis in a pregnant woman with acute ...
متن کاملRetrosternal mass: An interesting allergic reaction to intravenous thrombolytic therapy for acute ischemic stroke
Stroke is an important cause of disability and death worldwide, with the majority of strokes occurring in older people. Thrombolysis with recombinant tissue plasminogen activator (r-TPA) is the approved treatment for acute ischemic stroke. A major concern of physicians, who treat acute ischemic stroke with recombinant tissue plasminogen activator (r-TPA,) is the risk of intracerebral hemorrhage...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
دوره شماره
صفحات -
تاریخ انتشار 2014